APA সাইটেশন

Okita, R., Shimizu, K., Nojima, Y., Saisho, S., & Nakata, M. (2021). Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad. Thorac Cancer.

শিকাগো স্টাইলে সাইটেশন

Okita, Riki, Katsuhiko Shimizu, Yuji Nojima, Shinsuke Saisho, এবং Masao Nakata. "Tofacitinib Overcomes an IFNγ‐induced Decrease in NK Cell‐mediated Cytotoxicity Via the Regulation of Immune‐related Molecules in LC‐2/ad." Thorac Cancer 2021.

এমএলএ সাইটেশন

Okita, Riki, et al. "Tofacitinib Overcomes an IFNγ‐induced Decrease in NK Cell‐mediated Cytotoxicity Via the Regulation of Immune‐related Molecules in LC‐2/ad." Thorac Cancer 2021.

সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.